OKUR Valuation

Onkure Therapeutics Inc

Add to Watchlist

Advanced Chart

2.940

-0.22(-6.962%)1D

OKUR Relative Valuation

OKUR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, OKUR is overvalued; if below, it's undervalued.

Historical Valuation

Onkure Therapeutics Inc (OKUR) is now in the Fair zone, suggesting that its current forward PS ratio of 3.16 is considered Fairly compared with the five-year average of -1.63. The fair price of Onkure Therapeutics Inc (OKUR) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：2.94

Fair

-0.73

Trailing

Forward

0.00

EV/EBITDA

Onkure Therapeutics Inc. (OKUR) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.

0.58

EV/EBIT

Onkure Therapeutics Inc. (OKUR) has a current EV/EBIT of 0.58. The 5-year average EV/EBIT is -1.44. The thresholds are as follows: Strongly Undervalued below -6.93, Undervalued between -6.93 and -4.18, Fairly Valued between 1.31 and -4.18, Overvalued between 1.31 and 4.06, and Strongly Overvalued above 4.06. The current Forward EV/EBIT of 0.58 falls within the Historic Trend Line -Fairly Valued range.

3.16

Onkure Therapeutics Inc. (OKUR) has a current PS of 3.16. The 5-year average PS is 67.40. The thresholds are as follows: Strongly Undervalued below -134.61, Undervalued between -134.61 and -33.61, Fairly Valued between 168.40 and -33.61, Overvalued between 168.40 and 269.41, and Strongly Overvalued above 269.41. The current Forward PS of 3.16 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

Onkure Therapeutics Inc. (OKUR) has a current P/OCF of 0.00. The 5-year average P/OCF is -0.41. The thresholds are as follows: Strongly Undervalued below -1.46, Undervalued between -1.46 and -0.93, Fairly Valued between 0.12 and -0.93, Overvalued between 0.12 and 0.64, and Strongly Overvalued above 0.64. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

Onkure Therapeutics Inc. (OKUR) has a current P/FCF of 0.00. The 5-year average P/FCF is -0.41. The thresholds are as follows: Strongly Undervalued below -1.46, Undervalued between -1.46 and -0.93, Fairly Valued between 0.12 and -0.93, Overvalued between 0.12 and 0.64, and Strongly Overvalued above 0.64. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

Onkure Therapeutics Inc (OKUR) has a current Price-to-Book (P/B) ratio of 0.55. Compared to its 3-year average P/B ratio of -0.02 , the current P/B ratio is approximately -2290.42% higher. Relative to its 5-year average P/B ratio of -0.02, the current P/B ratio is about -2290.42% higher. Onkure Therapeutics Inc (OKUR) has a Forward Free Cash Flow (FCF) yield of approximately -1.49%. Compared to its 3-year average FCF yield of -112.94%, the current FCF yield is approximately -98.68% lower. Relative to its 5-year average FCF yield of -112.94% , the current FCF yield is about -98.68% lower.

0.55

P/B

Median3y

-0.02

Median5y

-0.02

-1.49

FCF Yield

Median3y

-112.94

Median5y

-112.94

Competitors Valuation Multiple

The average P/S ratio for OKUR's competitors is 5.66, providing a benchmark for relative valuation. Onkure Therapeutics Inc Corp (OKUR) exhibits a P/S ratio of 3.16, which is -44.19% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

OKUR.O

Onkure Therapeutics Inc

Tempest Therapeutics Inc

Cumberland Pharmaceuticals Inc

Actinium Pharmaceuticals Inc

1.26

39.31M

Performance Decomposition

Market capitalization of OKUR increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of OKUR in the past 1 year is driven by Unknown.